Unknown PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT05912946

Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis

Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis: a Randomized, Double-blind, Placebo-controlled Study

Sponsor: West China Hospital

Conditions Interstitial Cystitis

Interventions Interferon Sodium Chloride Injection Sodium Hyaluronate

Updated 5 times since 2023 Last updated: Sep 14, 2023 Started: Oct 15, 2023 Primary completion: Oct 15, 2024 Completion: Oct 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Interstitial Cystitis and is currently ongoing. West China Hospital leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Oct 2025 — Present [monthly]

Unknown PHASE2/PHASE3

Status: Not Yet Recruiting → Unknown
Sep 2024 — Oct 2025 [monthly]

Not Yet Recruiting PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Oct 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2_PHASE3
Jul 2023 — Oct 2023 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

West China Hospital

Data source: West China Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.